Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2021
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,137
+5.21%
|
-
|
|
Feb 23
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-2.07%
|
$28,480
$80.23 P/Share
|
|
Feb 23
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
790
-1.21%
|
$63,200
$80.23 P/Share
|
|
Feb 23
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-1.09%
|
$32,080
$80.23 P/Share
|
|
Feb 23
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.36%
|
$24,960
$80.23 P/Share
|
|
Feb 23
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-1.23%
|
$37,280
$80.23 P/Share
|
|
Feb 23
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314
-0.46%
|
$25,120
$80.23 P/Share
|
|
Feb 23
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,975
-0.55%
|
$158,000
$80.23 P/Share
|
|
Feb 21
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.07%
|
$11,360
$80.51 P/Share
|
|
Feb 21
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-1.87%
|
$26,240
$80.51 P/Share
|
|
Feb 21
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.99%
|
$29,280
$80.51 P/Share
|
|
Feb 21
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-0.32%
|
$22,000
$80.51 P/Share
|
|
Feb 21
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-1.32%
|
$40,400
$80.51 P/Share
|
|
Feb 21
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.4%
|
$22,160
$80.51 P/Share
|
|
Feb 21
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,039
-0.57%
|
$163,120
$80.51 P/Share
|
|
Feb 21
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-0.95%
|
$49,680
$80.51 P/Share
|
|
Feb 20
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.11%
|
$16,400
$80.51 P/Share
|
|
Feb 20
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-1.54%
|
$22,000
$80.51 P/Share
|
|
Feb 20
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-0.82%
|
$24,400
$80.51 P/Share
|
|
Feb 20
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-0.27%
|
$18,480
$80.51 P/Share
|
|
Feb 20
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
543
-1.4%
|
$43,440
$80.51 P/Share
|
|
Feb 20
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-0.36%
|
$19,760
$80.51 P/Share
|
|
Feb 20
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,743
-0.48%
|
$139,440
$80.51 P/Share
|
|
Feb 20
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-0.98%
|
$52,000
$80.51 P/Share
|
|
Jan 19
2021
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Jan 19
2021
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
405
+0.17%
|
$16,605
$41.63 P/Share
|
|
Jan 19
2021
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+0.33%
|
-
|
|
Jan 19
2021
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+0.32%
|
-
|
|
Jan 19
2021
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+0.31%
|
-
|
|
Jan 19
2021
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.32%
|
-
|
|
Jan 19
2021
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+0.32%
|
-
|
|
Jan 19
2021
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.32%
|
-
|
|
Jan 19
2021
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Jan 19
2021
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+0.16%
|
$10,209
$41.56 P/Share
|
|
Jan 19
2021
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.34%
|
-
|
|
Jan 19
2021
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
293
+0.15%
|
$12,013
$41.61 P/Share
|
|
Jan 19
2021
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Jan 04
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,306
-11.6%
|
$189,092
$82.69 P/Share
|
|
Jan 04
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,919
-13.01%
|
$813,358
$82.69 P/Share
|
|
Jan 04
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,058
-11.94%
|
$414,756
$82.69 P/Share
|
|
Jan 04
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,027
-2.28%
|
$166,214
$82.69 P/Share
|
|
Jan 04
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
5,872
-13.12%
|
$481,504
$82.69 P/Share
|
|
Jan 04
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,041
-2.87%
|
$167,362
$82.69 P/Share
|
|
Jan 04
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,894
-5.98%
|
$1,877,308
$82.69 P/Share
|
|
Nov 18
2020
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
81,031
+50.0%
|
-
|
|
Nov 18
2020
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
81,031
-51.52%
|
-
|
|
Nov 17
2020
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,650
-24.85%
|
$498,750
$75.22 P/Share
|
|
Oct 16
2020
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.42%
|
-
|
|
Oct 16
2020
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
943
+0.39%
|
$32,062
$34.21 P/Share
|
|
Oct 16
2020
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.4%
|
-
|